November 4, 2019
FDA: ICU Medical recalls Lactated Ringer’s Injection, 0.9% Sodium Chloride Injection
Editor's Note
The Food & Drug Administration on October 30 announced the nationwide recall by ICU Medical (San Clemente, California) of one lot of Lactated Ringer’s Injection, USP, and one lot of 0.9% Sodium Chloride Injection because of the presence of particulate matter.
The affected lot numbers are:
- Lactated Ringer’s Injection, USP: 84-603-FW
- 0.9% Sodium Chloride Injection, USP: 95-101-C6.
To date, ICU Medical has not received reports of adverse events related to this recall.
Free Daily News
- Study: COVID-19's impact on oncological surgery offers lessons for future crises
- Study links pandemic stress to persistent increases in nursing-sensitive quality indicators
- Save the date for the 2025 OR Business Management Conference
- Study: Education, exercise improve knee OA with or without prior surgery
- Study: Early surgery outperforms endoscopy for long-term pancreatitis
- Study: Blood thinner, NSAID combination raises bleeding risk
- Hospital financial report predicts stability, high cybersecurity costs for 2025
- IV fluid shortage drives innovation in hospital hydration practices
- FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators
- Five leadership lessons from an ASC CEO
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement